GNGeorgios Nikolakis

Georgios Nikolakis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Georgios Nikolakis has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Christos C. Zouboulis

    Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Auenweg 38, 06847, Dessau, Germany

    4 shared publications
  • Christos Constantin Zouboulis

    Department of Dermatology, Venereology, and Immunology, Universitaetsklinikum Ruppin-Brandenburg, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Neuruppin, Germany

    2 shared publications
  • A. G. Vaiopoulos

    Hochschulklinik für Dermatologie, Venerologie und Allergologie, Immunologisches Zentrum, Städtisches Klinikum Dessau, Medizinische Hochschule Theodor Fontane, Dessau, Deutschland

    1 shared publication
  • Andreas Altenburg

    Hochschulklinik für Dermatologie, Venerologie und Allergologie, Immunologisches Zentrum, Städtisches Klinikum Dessau, Medizinische Hochschule Brandenburg Theodor Fontane, Auenweg 38, 06847, Dessau, Deutschland

    1 shared publication
  • Andrzej T. Slominski

    Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.

    1 shared publication
  • Aristeidis Vaiopoulos

    Hochschulklinik für Dermatologie, Venerologie und Allergologie, Immunologisches Zentrum, Städtisches Klinikum Dessau, Medizinische Hochschule Brandenburg Theodor Fontane, Auenweg 38, 06847, Dessau, Deutschland

    1 shared publication

Latest Publications

  • Endokrine Mechanismen bei der Pathophysiologie der Hidradenitis suppurativa

    by G. Nikolakis, I. Karagiannidis, A. G. Vaiopoulos, M. Becker, C. C. Zouboulis

    Zusammenfassung Hidradenitis suppurativa (HS) ist eine chronische, rezidivierende Erkrankung des Haarfollikels, die sich mit druckdolenten Knoten, Abszessen und Fisteln manifestiert. Die Pathophysiologie der Erkrankung umfasst neben zahlreichen Faktoren auch dermatoendokrinologische Aspekte: Die Korrelation mit dem metabolischen Syndrom, mit Geschlechtshormonen, das Ansprechen auf Antiandrogene sind einige von den Punkten, die in diesem Review zusammengefasst und präsentiert werden. Die hormonelle Behandlung kann eine effektive und günstige Alternative oder Zusatztherapie zu den klassischen Therapieoptionen sein, insbesondere bei Fällen, in denen Antibiotika und/oder Biologika unwirksam oder kontraindiziert sind.


  • Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data

    by Georgios Nikolakis, Athanassios Kyrgidis, Christos C. Zouboulis

    Hidradenitis suppurativa/acne inversa is a disease with deep-seated chronic painful nodules, abscesses, and draining sinus tracts, which manifests on the apocrine gland-rich skin areas of the body. Observational findings demonstrate that the disease usually appears after puberty, exhibits pre-menstrual flares in women, improves in pregnancy, and worsens post-partum, which indicates a role of hormones and particularly of androgens in its pathophysiology. Because increased androgen levels in serum have not been widely reported, an end-organ androgen hypersensitivity has been postulated.


  • Mediastinale Lymphknotenvergrößerung bei einer Patientin mit malignem Melanom Stadium IV unter Therapie mit Pembrolizumab

    by Georgios Nikolakis, Martina Brunner, Heike Boye, Nicole Arndt, Andreas Altenburg, Aristeidis Vaiopoulos, Christos C. Zouboulis

    Eine 40-jährige Patientin mit malignem Melanom pT4bN0M1a Stadium IV (AJCC[American Joint Committee on Cancer]-Klassifikation 2017) wurde mit Pembrolizumab behandelt. Drei Monate nach Einleitung der Therapie zeigten sich neben der partiellen Remission der kutanen Metastasen bilateral auftretende Lymphknoten im Mediastinum. Eine elektive Lymphknotenexstirpation erfolgte, und das histologische Ergebnis war mit einer sarkoidähnlichen Reaktion vereinbar. Eine Pause der Therapie und die Stoßtherapie mit systemischen Steroiden brachten eine deutliche Remission der Lymphadenopathie. Diese außergewöhnliche Nebenwirkung kann sowohl bei PD-1(„programmed cell death protein-1“)/PD-L1(„programmed cell death ligand protein-1“)-Antikörper- als auch bei CTLA-4(„cytotoxic T‑lymphocyte-associated protein 4“)-Antikörpertherapie auftreten und soll in die Differenzialdiagnose einer mediastinalen Lymphadenopathie einbezogen werden. A 40-year-old patient with malignant melanoma pT4bN0M1a stage IV (AJCC classification 2017) was treated with the PD-1/PD-L1 antibody pembrolizumab. Three months after treatment initiation the patient developed enlarged mediastinal lymph nodes despite the partial response of the cutaneous metastases. An elective lymph node extirpation was performed. The histopathological result was consistent with a sarcoid-like reaction. Treatment was discontinued and a pulse therapy with systemic steroids led to a significant remission of the lymphadenopathy. This side effect can manifest both during PD-1/PD-L1 antibody and CTLA-4 antibody therapy and should be included in the differential diagnosis of mediastinal lymphadenopathy.


  • Experimental Models of Human Skin Aging

    by Georgios Nikolakis, Evgenia Makrantonaki, Christos C. Zouboulis


  • Skin steroidogenesis in health and disease

    by Georgios Nikolakis, Constantine A. Stratakis, Theodora Kanaki, Andrej Slominski, Christos C. Zouboulis

    The skin is an important extra-gonadal steroidogenic organ, capable of metabolizing various hormones from their precursors, as well as of synthesizing de novo a broad palette of sex steroids and glucocorticoids from cholesterol. In this manuscript, we review the major steroidogenic properties of human skin and we suggest steroidogenesis’ impairment as a cardinal factor for various pathological conditions such as acne, rosacea, atopic dermatitis, and androgenic alopecia.


  • Pigmentansammlungen im Wächterlymphknoten einer Patientin mit malignem Melanom

    by G. Nikolakis, V. A. Zampeli, M. Brunner, C. C. Zouboulis


  • Open Access

    Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis

    by Georgios Nikolakis, Christos C. Zouboulis

    The role of skin as a de novo source of glucocorticoids and the importance of cutaneous glucocorticoidogenesis as a homeostatic mechanism in human skin is highlighted by Slominski et al. in a recently published issue. Impairment of glucocorticoidogenesis through noxious stimuli, such as UVB, can explain pathophysiology of skin diseases (e.g. rosacea). In addition to keratinocytes, melanocytes and fibroblasts, cutaneous adnexes also play a significant role as targets and sources of glucocorticoids, because they express most of the enzymes required for steroidogenesis. Glucocorticoids are also involved in the pathogenesis of acne lesions, affecting sebum production in vivo and in vitro. Certain steroidogenic enzymes, such as 11β‐hydroxysteroid dehydrogenase, are upregulated in acne lesions. On this background, the paper by Slominski et al. provides further insights into dermatoendocrinology, with emphasis on the importance of an impairment of the skin's own hypothalamic–pituitary–adrenal‐like axis in the pathophysiology of several skin diseases.